Monoclonal antibodies for the early treatment of paediatric COVID-19 patients: a tangible contribution from hospital pharmacists in the lack of evidence-Reference-Cited by-同舟云学术

Monoclonal antibodies for the early treatment of paediatric COVID-19 patients: a tangible contribution from hospital pharmacists in the lack of evidence

Published:2022-10-06 Issue: Volume: Page:ejhpharm-2022-003562
ISSN:2047-9956
Container-title:European Journal of Hospital Pharmacy
language:en
Short-container-title:Eur J Hosp Pharm

Author:

Trivellato Sabrina,Mengato Daniele^ORCID,Donà Daniele,De Pieri Marica,Venturini Francesca

Publisher

BMJ

Subject

General Pharmacology, Toxicology and Pharmaceutics

Reference5 articles.

1. SARS-CoV-2 (COVID-19): what do we know about children? A systematic review;Mehta;Clin Infect Dis,2020

2. COVID-19 in children with cancer;Kahn;Curr Oncol Rep,2022

3. Pharmacokinetics and clinical pharmacology of monoclonal antibodies in pediatric patients;Temrikar;Paediatr Drugs,2020

4. Delgado BJ , Safadi AO , Bajaj T . Clark’s Rule. In: StatPearls. Treasure Island (FL): StatPearls Publishing, 2022. https://www.ncbi.nlm.nih.gov/books/NBK541104/

5. Early use of sotrovimab in children: a case report of an 11-year-old kidney transplant recipient infected with SARS-CoV-2;Di Chiara;Children,2022

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Community Pharmacy as a Study Center for the Epidemiological Analysis of the Population Vaccination against SARS-CoV-2: Evaluation of Vaccine Safety and Pharmaceutical Service;Pharmacy;2024-01-20

2. Early Treatments of Fragile Children with COVID-19—Results of CLEVER (Children COVID Early Treatment), a Retrospective, Observational Study;Viruses;2023-01-10